USP15 inhibits hypoxia‐induced IL ‐6 signaling by deubiquitinating and stabilizing MeCP2
The FEBS Journal · 2025
DOI: 10.1111/febs.17282 ↗At a glance
Journal article in The FEBS Journal, 2025. Written by Zi-Tong Zhang and 8 co-authors. Institution: School of Pharmacy, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong Univ…. Major MEDLINE topics: Methyl-CpG-Binding Protein 2, Interleukin-6, Signal Transduction, Ubiquitination. Cited 4 times so far (Crossref); 47 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (original language)
Methyl‐CpG binding protein 2 (MeCP2) is an important X‐linked DNA methylation reader and a key heterochromatin organizer. The expression level of MeCP2 is crucial, as indicated by the observation that loss‐of‐function mutations of MECP2 cause Rett syndrome, whereas an extra copy spanning the MECP2 locus results in MECP2 duplication syndrome, both being progressive neurodevelopmental disorders. Our previous study demonstrated that MeCP2 protein expression is rapidly induced by renal ischemia–reperfusion injury (IRI) and protects the kidney from IRI through transcriptionally repressing the interleukin‐6 (IL‐6)/signal transducer and activator of transcription 3 signaling pathway. However, the mechanisms underlying the upregulation of MeCP2 have remained elusive. Here, by using two hypoxia cell models, hypoxia and reoxygenation and cobalt chloride stimulation, we confirmed that the removal of lysine 48‐linked ubiquitination from MeCP2 prevented its proteasome‐dependent degradation under hypoxic conditions. Through unbiased screening based on a deubiquitinating enzymes library, we identified ubiquitin‐specific protease 15 (USP15) as a stabilizer of MeCP2. Further studies revealed that USP15 could attenuate hypoxia‐induced MeCP2 degradation by cleaving lysine 48‐linked ubiquitin chains from MeCP2, primarily targeting its C‐terminal domain. Consistently, USP15 inhibited hypoxia‐induced signal transducer and activator of transcription 3 activation, resulting in reduced transcription of IL‐6 downstream genes. In summary, our study reveals an important role for USP15 in the maintenance of MeCP2 stability and the regulation of IL‐6 signaling.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Pharmacy, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, China.
- Department of Laboratory Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Transfusion Medicine, Wuhan Hospital of Traditional Chinese and Western Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.
ORCID profiles: Yu Zhang
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Cite
APA
Zhang, Z. T., Niu, S. X., Yu, C. H., Wan, S. Y., Wang, J., Liu, C. Y., Zheng, L., Huang, K., & Zhang, Y. (2025). USP15 inhibits hypoxia‐induced IL ‐6 signaling by deubiquitinating and stabilizing MeCP2. The FEBS Journal. https://doi.org/10.1111/febs.17282
Vancouver
Zhang ZT, Niu SX, Yu CH, Wan SY, Wang J, Liu CY, et al. USP15 inhibits hypoxia‐induced IL ‐6 signaling by deubiquitinating and stabilizing MeCP2. The FEBS Journal. 2025. doi:10.1111/febs.17282
BibTeX
@article{Zhang2025,
author = {Zhang, Zi-Tong and Niu, Shu-Xuan and Yu, Chen-Hao and Wan, Shi-Yuan and Wang, Jiao and Liu, Cheng-Yu and Zheng, Ling and Huang, Kun and Zhang, Yu},
title = {USP15 inhibits hypoxia‐induced IL ‐6 signaling by deubiquitinating and stabilizing MeCP2},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.17282}
}
EUVIMED